[Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
Motaouakkil
S
S
Charra
B
B
Hachimi
A
A
Benslama
A
A
D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003091:Colistin / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology* / Q000628:therapy; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000382:microbiology* / Q000628:therapy; D012121:Respiration, Artificial; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D012293:Rifampin; D003091:Colistin